Two Russian companies, ANO Airalab Rus from Samara Oblast in the mid-Volga region and Innocolloid, Inc. from St. Petersburg, have been jointly working on what they refer to as “digital passport” for their new anti-viral blocker called Blokator.

The Blokator reportedly demonstrates disinfectant properties and is designed to thwart viral and microbial activity. Tests are said to have proved its efficacy in inhibiting human respiratory viruses—but the solution is not a drug in a strict therapeutic sense of the word.

The Russian solution is meant to compete with Japanese anti-viral blockers that currently dominate the blockers market.